| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 56.712 | 71.905 | 113.983 | 159.724 | 145.959 | 159.697 | 170.334 | 248.488 | 357.220 | 405.087 |
| Total Income - EUR | 56.886 | 72.313 | 114.171 | 161.875 | 146.331 | 160.362 | 170.982 | 249.982 | 359.040 | 406.230 |
| Total Expenses - EUR | 53.739 | 63.494 | 96.960 | 124.178 | 134.127 | 133.700 | 160.176 | 236.780 | 297.527 | 327.809 |
| Gross Profit/Loss - EUR | 3.147 | 8.819 | 17.211 | 37.696 | 12.204 | 26.662 | 10.806 | 13.202 | 61.513 | 78.421 |
| Net Profit/Loss - EUR | 1.420 | 8.069 | 16.067 | 36.172 | 10.861 | 25.346 | 9.224 | 11.119 | 57.999 | 66.442 |
| Employees | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 4 | 5 | 4 |
Check the financial reports for the company - Opticlinic Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.322 | 7.772 | 6.072 | 50.547 | 81.490 | 62.989 | 50.445 | 109.318 | 102.845 | 73.454 |
| Current Assets | 25.989 | 30.729 | 39.414 | 75.471 | 46.197 | 64.301 | 53.056 | 79.528 | 98.887 | 118.705 |
| Inventories | 16.247 | 27.634 | 34.727 | 23.016 | 27.878 | 20.592 | 31.939 | 61.589 | 61.606 | 36.023 |
| Receivables | 3.633 | 3.096 | 3.947 | 19.030 | 7.302 | 8.194 | 1.755 | 2.967 | 15.519 | 13.375 |
| Cash | 6.109 | -1 | 740 | 33.426 | 11.018 | 35.515 | 19.362 | 14.972 | 21.762 | 69.308 |
| Shareholders Funds | 3.643 | 11.674 | 27.544 | 63.210 | 72.847 | 84.408 | 71.545 | 78.617 | 116.824 | 120.671 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 28.668 | 26.827 | 17.942 | 62.807 | 55.011 | 43.020 | 31.956 | 110.317 | 85.440 | 71.738 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Opticlinic Med Srl